Shaanxi Micot Pharmaceutical Technology Co., Ltd. (SEHK: 2335)
Health Care · Biotechnology · CN
HK$19.80
-3.79% today · -46.3% 1Y
Shaanxi Micot Pharmaceutical Technology Co., Ltd. (SEHK: 2335) operates in the Biotechnology industry within the Health Care sector. The company is valued at $837.23M and employs 121 people.
Over the last twelve months the share price has lost 46.3%, trading between 11.41 and 45.04.
Tweenvest scores Shaanxi Micot Pharmaceutical Technology Co., Ltd. across four factors: quality 19/100, value 100/100. Its strongest factor is value.
2335 price history
Key figures
- Market cap
- $837.23M
- Revenue (TTM)
- —
- P/E
- -38.95
- EPS
- -0.84
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- HK$45.04
- 52-week low
- HK$11.41
- Avg volume (3M)
- —
- Shares outstanding
- 331.74M
- Employees
- 121
- Next earnings
- —
About Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Shaanxi Mycotech Pharmaceutical Technology Co., Ltd. operates as a platform-based biotechnology company dedicated to accelerating the global innovation and development of next-generation bi-multi-specific peptide drugs. Its products include MT1013, which is a dual-targeting receptor agonist polypeptide that simultaneously targets the CaSR and the OGP receptor. It is designed for the treatment of SHPT, CKD-MBD with Osteoporosis and SHPT not on Dialysis. The company was founded by Wang Bing on January 19, 2007 and is headquartered in Xi'an, China.
- ISIN
- CNE100007Q79
- Founded
- 2007
- Listed since
- Jun 24, 2026
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Verastem, Inc.NasdaqCM: VSTM | $865.72M | $6.87 | -7.29% |
| Hangzhou Biotest Biotech Co.,Ltd.SHSE: 688767 | $860.61M | CN¥39.26 | +1.11% |
| Syndax Pharmaceuticals, Inc.NasdaqGS: SNDX | $858.87M | $9.54 | -0.52% |
| Seegene, Inc.KOSDAQ: A096530 | $841.38M | ₩24,650.00 | -1.79% |
| City Therapeutics, Inc.NasdaqGM: CTY | $827.95M | $16.64 | -4.91% |
| Bambusa Therapeutics, Inc.NasdaqGS: BBTX | $814.06M | $15.98 | -0.68% |
| L&C BIO Co.,LTDKOSDAQ: A290650 | $813.06M | ₩20,150.00 | -6.06% |
| Aimed Bio Inc.KOSDAQ: A0009K0 | $802.22M | ₩16,500.00 | -9.89% |